HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates

Journal of Clinical Virology

Volumn 35, Issue 3, 2006, Pages 244-249

  Fuente, Luis De La ^a,b   Toro, Carlos ^c   Soriano, Vicente ^c   Brugal, M Teresa ^d   Vallejo, Fernando ^a   Barrio, Gregorio ^e   Jiménez, Victoria ^c   Silva, Teresa ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b Secretaria del Plan Nacional sobre el Sida   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e Delegacion Gobierno Plan Nac Drogas   (Spain)

Author keywords

Epidemiology; Human T cell lymphotropic virus; Prevalence

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PRISON; QUESTIONNAIRE; RISK FACTOR; SELF INJECTION; SPAIN;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; PREVALENCE; RISK FACTORS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 31944434714     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.06.006     Document Type: Article

References (20)

1. M.J. Belza Prevalence of HIV, HTLV-I and HTLV-II among female sex workers in Spain, 2000-2001 Eur. J. Epidemiol. 19 3 2004 279 282
2. M.J. Bravo, L. Royuela, G. Barrio, M.A. Rodriguez-Arenas, and L. de la Fuente Prevalence of indirect sharing of drug-injecting paraphernalia in Galicia, Madrid, Seville and Valencia [Spain] Gac. Sanit. 18 6 2004 472 478
3. L. de la Fuente, G. Barrio, L. Royuela, and M.J. Bravo The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration Addiction 92 12 1997 1749 1763
4. Delegación del Gobierno para el Plan Nacional sobre Drogas, 2003. Observatorio español sobre drogas, informe no. 6, Ministerio del Interior, Madrid.
5. M.A. Fernandez Sierra, M. Gomez Olmedo, M. Delgado Rodriguez, and R. Galvez Vargas Infección por el virus de la inmunodeficiencia humana en población española (II). Meta-análisis de las tendencias temporales y geográficas Med. Clin. (Barc.) 95 10 1990 366 371
6. P. Goubau, P. Wantzin, A. Gessain, D. Jeannel, J. Coste, and G. Pauli Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe J Acquir Immune Defic Syndr Hum Retrovirol 13 1 1996 68 77
7. D.D. Heckathorn Respondent-driven sampling: a new approach to the study of hidden populations Soc Probl 44 1997 174 179
8. D.R. Henrard, V. Soriano, E. Robertson, M. Gutierrez, J. Stephens, and F. Dronda Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group J Clin Microbiol 33 7 1995 1735 1738
9. S.C. Lemon, J. Roy, M.A. Clark, P.D. Friedmann, and W. Rakowski Classification and regression tree analysis in public health: methodological review and comparison with logistic regression Ann Behav Med 26 3 2003 172 181
10. A. Machuca, C. Tuset, V. Soriano, E. Caballero, A. Aguilera, and D.L. Ortiz Prevalence of HTLV infection in pregnant women in Spain Sex Transm Infect 76 5 2000 366 370
11. R.J. Marshall The use of classification and regression trees in clinical epidemiology J Clin Epidemiol 54 6 2001 603 609
12. S.P. Parker, and W.D. Cubitt The use of the dried blood spot sample in epidemiological studies J Clin Pathol 52 9 1999 633 639
13. D.F. Roucoux, and E.L. Murphy The epidemiology and disease outcomes of human T-lymphotropic virus type II AIDS Rev 6 3 2004 144 154
14. K. Roy, G. Hay, R. Andragetti, A. Taylor, D. Goldberg, and L. Wiessing Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature Epidemiol Infect 129 3 2002 577 585
15. G.B. Schreiber, E.L. Murphy, J.A. Horton, D.J. Wright, R. Garfein, and H.C. Chien Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study J. Acquir Immune Defic Syndr Hum Retrovirol 14 3 1997 263 271
16. SPSS Inc. Answer Tree 2.0 SPSS Inc. Chicago; 1998.
17. SPSS Inc. SPSS 12.0 for Windows SPSS Inc. Chicago; 2003.
18. C. Toro, B. Rodes, A. Aguilera, E. Caballero, R. Benito, and S. Bassani HIV-2 and HTLV-I/II infections in Spain Enferm Infecc Microbiol Clin 22 3 2004 177 182
19. A. Vallejo, and A. Garciasaiz Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain-reaction - application to clinical specimens J Virol Methods 51 1 1995 9 17
20. J.K. Watters, and P. Biernacki Targeted sampling: options for the study of hidden populations Soc Probl 36 4 1989 416 430